We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.85%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$247B
AUM Growth
-$11.7B
(-4.5%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-0.44%
Top 10 Holdings %
Top 10 Hldgs %
21.96%
Holding
3,327
New
107
Increased
1,095
Reduced
1,938
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.11B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$300M |
| 3 |
Baxter International
BAX
|
+$237M |
| 4 |
American Tower
AMT
|
+$196M |
| 5 |
UnitedHealth
UNH
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$343M |
| 2 |
Meta Platforms (Facebook)
META
|
+$300M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
Salesforce
CRM
|
+$266M |
| 5 |
Match Group
MTCH
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 15.1% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
3D Systems Corp
DDD
$613M
| $3.81M | ﹤0.01% |
477,192
+5,654
| +1% | +$58.1K |
|
2027
Intrepid Potash
IPI
$469M
| $3.81M | ﹤0.01% |
96,195
+715
| +0.7% | +$31K |
|
|
FARO
2028
DELISTED
Faro Technologies
FARO
| $3.79M | ﹤0.01% |
137,991
+24,156
| +21% | +$787K |
|
2029
Coeur Mining
CDE
$17.9B
| $3.78M | ﹤0.01% |
1,105,685
-13,456
| -1% | -$39.9K |
|
2030
Cerus
CERS
$474M
| $3.77M | ﹤0.01% |
1,047,915
+13,062
| +1% | +$62.5K |
|
2031
TriMas Corp
TRS
$1.44B
| $3.77M | ﹤0.01% |
150,418
-4,041
| -3% | -$111K |
|
2032
Encore Capital Group
ECPG
$2.13B
| $3.76M | ﹤0.01% |
82,773
-100,397
| -55% | -$5.77M |
|
|
PMT
2033
PennyMac Mortgage Investment
PMT
$842M
| $3.75M | ﹤0.01% |
318,802
-7,981
| -2% | -$117K |
|
2034
Allogene Therapeutics
ALLO
$694M
| $3.75M | ﹤0.01% |
347,169
-227,183
| -40% | -$3.09M |
|
2035
Southside Bancshares
SBSI
$967M
| $3.75M | ﹤0.01% |
105,951
+462
| +0.4% | +$17.7K |
|
2036
Liquidity Services
LQDT
$1.32B
| $3.74M | ﹤0.01% |
230,245
+77,159
| +50% | +$1.36M |
|
2037
Sportsman's Warehouse
SPWH
$46M
| $3.74M | ﹤0.01% |
450,528
-2,221
| -0.5% | -$21K |
|
|
RTL
2038
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
| $3.72M | ﹤0.01% |
633,102
-249,400
| -28% | -$1.84M |
|
2039
SkinHealth Systems
SKIN
$85.7M
| $3.72M | ﹤0.01% |
315,335
-9,218
| -3% | -$117K |
|
2040
Rocket Pharmaceuticals
RCKT
$394M
| $3.71M | ﹤0.01% |
232,389
-127,151
| -35% | -$1.98M |
|
2041
Smith & Wesson
SWBI
$637M
| $3.71M | ﹤0.01% |
357,390
+15,446
| +5% | +$204K |
|
|
BRMK
2042
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
| $3.7M | ﹤0.01% |
724,707
+286,982
| +66% | +$1.92M |
|
2043
American Vanguard Corp
AVD
$68.9M
| $3.7M | ﹤0.01% |
197,995
-112,816
| -36% | -$2.35M |
|
2044
Luxfer Holdings
LXFR
$458M
| $3.7M | ﹤0.01% |
255,336
+60,782
| +31% | +$963K |
|
2045
Nelnet
NNI
$4.7B
| $3.69M | ﹤0.01% |
46,641
-2,149
| -4% | -$187K |
|
|
PRO
2046
DELISTED
PROS Holdings
PRO
| $3.69M | ﹤0.01% |
149,348
-2,974
| -2% | -$72.1K |
|
|
NWLG
2047
DELISTED
Nuveen Winslow Large-Cap Growth ESG ETF
NWLG
| $3.69M | ﹤0.01% |
220,000
| – | – |
|
2048
Independent Bank Corp
IBCP
$844M
| $3.69M | ﹤0.01% |
192,948
+28,954
| +18% | +$587K |
|
2049
BridgeBio Pharma
BBIO
$16.5B
| $3.67M | ﹤0.01% |
369,564
-291,267
| -44% | -$3.03M |
|
|
BBBY
2050
Bed Bath & Beyond
BBBY
$442M
| $3.67M | ﹤0.01% |
165,672
-3,455
| -2% | -$86.6K |
|
Similar funds
VFT
Nuveen's Q3 2022 Portfolio in Review
As of Q3 2022, Nuveen held 3,327 positions worth $247B, down 4.5% from $259B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 5%. Nuveen opened 107 new positions and exited 58, leaving the 3,327-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q3 2022 buy was Alibaba: 1,014,906 shares worth $81.2M.
- Nuveen added most to Alnylam Pharmaceuticals in Q3 2022, an estimated $3.11B increase.
- Nuveen's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $343M.
- Nuveen fully exited Atlassian in Q3 2022, selling an estimated $82.9M.
- Nuveen's ten largest holdings make up 22% of its $247B portfolio in Q3 2022.
- Nuveen opened 107 new positions and closed 58 in Q3 2022.
- Nuveen's portfolio value fell 4.5% quarter-over-quarter to $247B.
Based on Nuveen's 13F filing for Q3 2022, filed 14 Nov 2022.